Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Engineering a patient’s own immune cells to resist HIV could eliminate the need for lifelong antiretroviral therapies.
Nearly 1.5 million people die from tuberculosis every year, even though most cases can be cured with routine antibiotic treatments. One country’s fight to get the ancient scourge under control has an unlikely hero: a simple diagnostic test.
Researchers will test four experimental vaccines in a region in South Africa where one in five adults is infected with HIV.
Research offers insights into how some HIV-positive people are able to avoid the full-blown disease.
High-performance disposable electronics could improve the quality of inexpensive tests.
A diverse group of antibodies may work together to neutralize the virus, suggesting a new approach to vaccination.